TheProfitWatch

RARE - Ultragenyx Pharmaceutical Inc.

Day 1m 10m 60m PreMarket Market AfterHours Gap
32.31 1.34 (4.16%) 0.0 (-0.01%) -0.05 (-0.16%) 0.31 (0.94%) 0.0 (0.0%) 2.14 (6.77%) --- 0.0 (0.0%)

Ultragenyx Pharmaceutical Inc is a USA-based biopharmaceutical company. It identifies, acquires, develops, and commercializes novel products for the treatment of serious rare and ultra-rare diseases, with a focus on serious, debilitating genetic diseases. The company's medicine portfolio includes Crysvita, Dojolvi and Mepsevii. Crysvita is indicated for the treatment of X-linked hypophosphatemia (XLH) in adult and pediatric patients 1 year of age and older. Mepsevii is indicated in pediatric and adult patients for the treatment of Mucopolysaccharidosis VII.

Category: PHARMACEUTICAL PREPARATIONS
Market Period: Market

Earnings & Ratios

Basic EPS:
-1.17
Diluted EPS:
-1.17
Basic P/E:
-28.765
Diluted P/E:
-28.765
RSI(14) 1m:
78.85
VWAP:
33.67
RVol:

Events

Period Kind Movement Occurred At

Related News